Pure Global

Medicine administration kit, percutaneous, medicated, single-use

Access comprehensive regulatory information for Medicine administration kit, percutaneous, medicated, single-use in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class I is sponsored by Abbvie Pty Ltd, manufactured by Abbvie Inc in United States of America. The device registration started on August 09, 2019.

This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.

Free Database
Powered by Pure Global AI
TGA ARTG Official Data
Class I
Class I
Medicine administration kit, percutaneous, medicated, single-use
Australia TGA ARTG Registered Device
Good Name: Abbvie Pty Ltd - Medicine administration kit, percutaneous, medicated, single-use
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Intended Purpose

Skyrizi procedure pack containing a pre-filled syringe containing risankizumab solution for injection and a cleansing alcohol swab.

Device Classification
Risk Class
Class I
Product Type
Procedure Pack
ARTG Category
General
Registration Information
Start Date
August 09, 2019
Effective Date
August 09, 2019
Sponsor
Manufacturer
Country
United States of America
Address
1 North Waukegan Road, North Chicago, IL, 60064